The immunomodulatory parasitic worm product ES-62 reduces lupus-associated accelerated atherosclerosis in a mouse model
- 1 March 2015
- journal article
- Published by Elsevier in International Journal for Parasitology
- Vol. 45 (4) , 203-207
Abstract
No abstract availableKeywords
Funding Information
- Wellcome Trust, UK (086852)
- NIH (PO1 R050256, K01 AR055965-02)
- NIAMS (R21 AR063387-01)
This publication has 27 references indexed in Scilit:
- Decreased Prevalence of Lymphatic Filariasis Among Subjects with Type-1 DiabetesThe American Journal of Tropical Medicine and Hygiene, 2010
- Effects of Schistosoma mansoni worms and eggs on circulating cholesterol and liver lipids in miceAtherosclerosis, 2009
- Prevalence of conventional and lupus‐specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case–control studyArthritis Care & Research, 2006
- Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertensionAtherosclerosis, 2006
- FILARIAL NEMATODE SECRETED PRODUCT ES‐62 IS AN ANTI‐INFLAMMATORY AGENT: THERAPEUTIC POTENTIAL OF SMALL MOLECULE DERIVATIVES AND ES‐62 PEPTIDE MIMETICSClinical and Experimental Pharmacology and Physiology, 2006
- Impaired Clearance of Apoptotic Cells Promotes Synergy between Atherogenesis and Autoimmune DiseaseJournal of Experimental Medicine, 2004
- An anti-atherogenic effect of Schistosoma mansoni infections in mice associated with a parasite-induced lowering of blood total cholesterolParasitology, 2002
- Accelerated atherosclerosis: An extraarticular feature of rheumatoid arthritis?Arthritis & Rheumatism, 2002
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cellsCell, 1992